Mitochondria-targeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing

Biotechnology Advances

Volumn 31, Issue 5, 2013, Pages 563-592

  Gruber, Jan ^a   Fong, Sheng ^a   Chen, Ce Belle ^a   Yoong, Sialee ^b   Pastorin, Giorgia ^b,c   Schaffer, Sebastian ^a   Cheah, Irwin ^a   Halliwell, Barry ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Age related diseases; Ageing; Health span; Mitochondria targeted antioxidants; Nanotechnology; Oxidative stress; Reactive oxygen species

Indexed keywords

AGE-RELATED DISEASE; AGEING; DEMOGRAPHIC CHANGES; MITOCHONDRIAL DYSFUNCTION; MITOCHONDRIAL FUNCTION; NEURODEGENERATION; REACTIVE OXYGEN SPECIES; UNCOUPLING PROTEINS;

CELL DEATH; METABOLISM; NANOTECHNOLOGY; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; OXYGEN;

MITOCHONDRIA;

ANTIOXIDANT; NANOPARTICLE;

AGING; CANCER; CARDIOVASCULAR DISEASE; DEMOGRAPHIC SURVEY; DISEASE INCIDENCE; METABOLISM; MORBIDITY; MORTALITY RISK; NANOTECHNOLOGY; OXIDATION; OXYGEN;

AGING; ANIMAL; DRUG EFFECT; HUMAN; METABOLISM; METHODOLOGY; MITOCHONDRION; NANOMEDICINE; REVIEW;

AGING; ANIMALS; ANTIOXIDANTS; HUMANS; MITOCHONDRIA; NANOMEDICINE; NANOPARTICLES;

EID: 84879409744     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.09.005     Document Type: Review

References (345)

1. Abbatecola A.M., Paolisso G., Fattoretti P., Evans W.J., Fiore V., Dicioccio L., et al. Discovering pathways of sarcopenia in older adults: a role for insulin resistance on mitochondria dysfunction. J Nutr Health Aging 2011, 15:890-895.
2. Adams A.E., Hanrahan O., Nolan D.N., Voorheis H.P., Fallon P., Porter R.K. Images of mitochondrial UCP 1 in mouse thymocytes using confocal microscopy. Biochim Biophys Acta 2008, 1777:115-117.
3. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A., Murphy M.P., et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J: official publication of the Federation of American Societies for Experimental Biology 2005, 19:1088-1095.
4. Akanmu D., Cecchini R., Aruoma O.I., Halliwell B. The antioxidant action of ergothioneine. Arch Biochem Biophys 1991, 288:10-16.
5. Akita H., Kudo A., Minoura A., Yamaguti M., Khalil I.A., Moriguchi R., et al. Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step wise membrane fusion process. Biomaterials 2009, 30:2940-2949.
6. Ali S.S., Hardt J.I., Quick K.L., Kim-Han J.S., Erlanger B.F., Huang T.T., et al. A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic Biol Med 2004, 37:1191-1202.
7. Amara C.E., Shankland E.G., Jubrias S.A., Marcinek D.J., Kushmerick M.J., Conley K.E. Mild mitochondrial uncoupling impacts cellular aging in human muscles in vivo. sProc Natl Acad Sci U S A 2007, 104:1057-1062.
8. Ames B.N. Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage. Proc Natl Acad Sci U S A 2006, 103:17589-17594.
9. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009, 119:573-581.
10. Andrews Z.B., Horvath T.L. Uncoupling protein-2 regulates lifespan in mice. Am J Physiol Endocrinol Metab 2009, 296:E621-E627.
11. Andrews Z.B., Horvath B., Barnstable C.J., Elsworth J., Yang L., Beal M.F., et al. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson's disease. J Neurosci 2005, 25:184-191.
12. Andrievsky G.V., Bruskov V.I., Tykhomyrov A.A., Gudkov S.V. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Radic Biol Med 2009, 47:786-793.
13. Anisimov V.N., Khavinson V., Popovich I.G., Zabezhinski M.A., Alimova I.N., Rosenfeld S.V., et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology 2003, 4:193-202.
14. Anisimov V.N., Bakeeva L.E., Egormin P.A., Filenko O.F., Isakova E.F., Manskikh V.N., et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 5. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry (Mosc) 2008, 73:1329-1342.
15. Anisimov V.N., Berstein L.M., Popovich I.G., Zabezhinski M.A., Egormin P.A., Piskunova T.S., et al. If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany NY) 2011, 3:148-157.
16. Anisimov V.N., Egorov M.V., Krasilshchikova M.S., Lyamzaev K.G., Manskikh V.N., Moshkin M.P., et al. Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging 2011, 3:1110-1119.
17. Ankola D.D., Viswanad B., Bhardwaj V., Ramarao P., Kumar M.N. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy?. Eur J Pharm Biopharm 2007, 67:361-369.
18. Antonenko Y.N., Roginsky V.A., Pashkovskaya A.A., Rokitskaya T.I., Kotova E.A., Zaspa A.A., et al. Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments. J Membr Biol 2008, 222:141-149.
19. Armstrong J.S., Whiteman M., Yang H., Jones D.P. The redox regulation of intermediary metabolism by a superoxide-aconitase rheostat. Bioessays 2004, 26:894-900.
20. Arsenijevic D., Onuma H., Pecqueur C., Raimbault S., Manning B.S., Miroux B., et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000, 26:435-439.
21. Aruoma O.I., Whiteman M., England T.G., Halliwell B. Antioxidant action of ergothioneine: assessment of its ability to scavenge peroxynitrite. Biochem Biophys Res Commun 1997, 231:389-391.
22. Aruoma O.I., Spencer J.P., Mahmood N. Protection against oxidative damage and cell death by the natural antioxidant ergothioneine. Food Chem Toxicol 1999, 37:1043-1053.
23. Asami D.K., McDonald R.B., Hagopian K., Horwitz B.A., Warman D., Hsiao A., et al. Effect of aging, caloric restriction, and uncoupling protein 3 (UCP3) on mitochondrial proton leak in mice. Exp Gerontol 2008, 43:1069-1076.
24. Ashcroft F.M., Harrison D.E., Ashcroft S.J. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 1984, 312:446-448.
25. Asin-Cayuela J., Manas A.R., James A.M., Smith R.A., Murphy M.P. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 2004, 571:9-16.
26. Asmus K.D., Bensasson R.V., Bernier J.L., Houssin R., Land E.J. One-electron oxidation of ergothioneine and analogues investigated by pulse radiolysis: redox reaction involving ergothioneine and vitamin C. Biochem J 1996, 315:625-629.
27. Azzone G.F., Pietrobon D., Zoratti M. Determination of the proton electrochemical gradient across biological membranes. Curr Top Bioenerg 1984, 13:1-77.
28. Baati T., Bourasset F., Gharbi N., Njim L., Abderrabba M., Kerkeni A., et al. Corrigendum to "The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene" [Biomaterials 33 (2012) 4936-4946]. Biomaterials 2012, 33:6292-6294.
29. Baati T., Bourasset F., Gharbi N., Njim L., Abderrabba M., Kerkeni A., et al. The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene. Biomaterials 2012, 33:4936-4946.
30. Bae Y.S., Oh H., Rhee S.G., Yoo Y.D. Regulation of reactive oxygen species generation in cell signaling. Mol Cells 2011, 32:491-509.
31. Bagatin E., Parada M.O., Miot H.A., Hassun K.M., Michalany N., Talarico S. A randomized and controlled trial about the use of oral isotretinoin for photoaging. Int J Dermatol 2010, 49:207-214.
32. Bakeeva L.E., Barskov I.V., Egorov M.V., Isaev N.K., Kapelko V.I., Kazachenko A.V., et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc) 2008, 73:1288-1299.
33. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants, and aging. Cell 2005, 120:483-495.
34. Barros M.H., Bandy B., Tahara E.B., Kowaltowski A.J. Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae. J Biol Chem 2004, 279:49883-49888.
35. Beebe-Dimmer J.L., Pfeifer J.R., Engle J.S., Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005, 15:175-184.
36. Biewenga G.P., Haenen G.R., Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997, 29:315-331.
37. Biswas S., Dodwadkar N.S., Sawant R.R., Koshkaryev A., Torchilin V.P. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. J Drug Target 2011.
38. Blaikie F.H., Brown S.E., Samuelsson L.M., Brand M.D., Smith R.A., Murphy M.P. Targeting dinitrophenol to mitochondria: limitations to the development of a self-limiting mitochondrial protonophore. Biosci Rep 2006, 26:231-243.
39. Boddapati S.V., D'Souza G.G., Erdogan S., Torchilin V.P., Weissig V. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett 2008, 8:2559-2563.
40. Boss O., Samec S., Paoloni-Giacobino A., Rossier C., Dulloo A., Seydoux J., et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997, 408:39-42.
41. Bouillaud F. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing. Biochim Biophys Acta 2009, 1787:377-383.
42. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995, 92:7297-7301.
43. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973, 134:707-716.
44. Bowling A.C., Beal M.F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 1995, 56:1151-1171.
45. Brand M.D. Measurement of mitochondrial protonmotive force. Bioenergetics: a practical approach 1995, 39-62. Oxford University Press, Oxford. G.C. Brown, C.E. Cooper (Eds.).
46. Brand M.D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp Gerontol 2000, 35:811-820.
47. Brand M.D., Esteves T.C. Physiological functions of the mitochondrial uncoupling proteins UCP2 and UCP3. Cell Metab 2005, 2:85-93.
48. Brand M.D., Pamplona R., Portero-Otin M., Requena J.R., Roebuck S.J., Buckingham J.A., et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochem J 2002, 368:597-603.
49. Brand M.D., Affourtit C., Esteves T.C., Green K., Lambert A.J., Miwa S., et al. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 2004, 37:755-767.
50. Cadenas S., Echtay K.S., Harper J.A., Jekabsons M.B., Buckingham J.A., Grau E., et al. The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3. J Biol Chem 2002, 277:2773-2778.
51. Cai X., Jia H., Liu Z., Hou B., Luo C., Feng Z., et al. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease. J Neurosci Res 2008, 86:3622-3634.
52. Caldeira da Silva C.C., Cerqueira F.M., Barbosa L.F., Medeiros M.H., Kowaltowski A.J. Mild mitochondrial uncoupling in mice affects energy metabolism, redox balance and longevity. Aging Cell 2008, 7:552-560.
53. Calin Viorel Pop i. Transport and Delivery of Glutathione into Human Cells Using Gold Nanoparticles. United States Patent Application Publication, US 201110111002 A1 May 12, 2011. 2011.
54. Cassano R., Trombino S., Muzzalupo R., Tavano L., Picci N. A novel dextran hydrogel linking trans-ferulic acid for the stabilization and transdermal delivery of vitamin E. Eur J Pharm Biopharm 2009, 72:232-238.
55. Cassidy-Stone A., Chipuk J.E., Ingerman E., Song C., Yoo C., Kuwana T., et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 2008, 14:193-204.
56. Chaturvedi R.K., Beal M.F. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci 2008, 1147:395-412.
57. Cheah I.K., Halliwell B. Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim Biophys Acta 2012, 1822:784-793.
58. Chen Y.W., Hwang K.C., Yen C.C., Lai Y.L. Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regul Integr Comp Physiol 2004, 287:R21-R26.
59. Chen J., Patil S., Seal S., McGinnis J.F. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol 2006, 1:142-150.
60. Chistyakov V.A., Sazykina M.A., Alexandrova A.A., Belichenko N.I., Mashkina E.V., Gutnikova L.V., et al. Antimutagenic activity of mitochondria-targeted plastoquinone derivative. Biochemistry (Mosc) 2010, 75:269-273.
61. Chng H.T., New L.S., Neo A.H., Goh C.W., Browne E.R., Chan E.C. Distribution study of orally administered lipoic acid in rat brain tissues. Brain Res 2009, 1251:80-86.
62. Cho J., Won K., Wu D., Soong Y., Liu S., Szeto H.H., et al. Potent mitochondria-targeted peptides reduce myocardial infarction in rats. Coron Artery Dis 2007, 18:215-220.
63. Cho S., Szeto H.H., Kim E., Kim H., Tolhurst A.T., Pinto J.T. A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem 2007, 282:4634-4642.
64. Cirillo G., Hampel S., Klingeler R., Puoci F., Iemma F., Curcio M., et al. Antioxidant multi-walled carbon nanotubes by free radical grafting of gallic acid: new materials for biomedical applications. J Pharm Pharmacol 2011, 63:179-188.
65. 2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab 2011, 13:340-350.
66. Colman E. Dinitrophenol and obesity: an early twentieth-century regulatory dilemma. Regul Toxicol Pharmacol 2007, 48:115-117.
67. Colognato R., Laurenza I., Fontana I., Coppede F., Siciliano G., Coecke S., et al. Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine. Clin Nutr 2006, 25:135-145.
68. Conti B., Sugama S., Lucero J., Winsky-Sommerer R., Wirz S.A., Maher P., et al. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity. J Neurochem 2005, 93:493-501.
69. Conti B., Sanchez-Alavez M., Winsky-Sommerer R., Morale M.C., Lucero J., Brownell S., et al. Transgenic mice with a reduced core body temperature have an increased life span. Science 2006, 314:825-828.
70. Couvreur P., Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharm Res 2006, 23:1417-1450.
71. Crabb D.W., Yount E.A., Harris R.A. The metabolic effects of dichloroacetate. Metabolism 1981, 30:1024-1039.
72. Cui M., Tang X., Christian W.V., Yoon Y., Tieu K. Perturbations in mitochondrial dynamics induced by human mutant PINK1 can be rescued by the mitochondrial division inhibitor mdivi-1. J Biol Chem 2010, 285:11740-11752.
73. Cunha F.M., Caldeira da Silva C.C., Cerqueira F.M., Kowaltowski A.J. Mild mitochondrial uncoupling as a therapeutic strategy. Curr Drug Targets 2011, 12:783-789.
74. Cunningham S.A., Wiesinger H., Nicholls D.G. Quantification of fatty acid activation of the uncoupling protein in brown adipocytes and mitochondria from the guinea-pig. Eur J Biochem 1986, 157:415-420.
75. Dai D.F., Rabinovitch P.S. Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med 2009, 19:213-220.
76. Dai D.F., Chen T., Wanagat J., Laflamme M., Marcinek D.J., Emond M.J., et al. Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell 2010, 9:536-544.
77. Darlenski R., Surber C., Fluhr J.W. Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach. Br J Dermatol 2010, 163:1157-1165.
78. Das M., Patil S., Bhargava N., Kang J.F., Riedel L.M., Seal S., et al. Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 2007, 28:1918-1925.
79. Dauer W., Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
80. de Magalhaes J.P., Church G.M. Cells discover fire: employing reactive oxygen species in development and consequences for aging. Exp Gerontol 2006, 41:1-10.
81. Demeneix B., Behr J.P. Polyethylenimine (PEI). Adv Genet 2005, 53:217-230.
82. Demianenko I.A., Vasilieva T.V., Domnina L.V., Dugina V.B., Egorov M.V., Ivanova O.Y., et al. Novel mitochondria-targeted antioxidants, "Skulachev-ion" derivatives, accelerate dermal wound healing in animals. Biochem Biokhim 2010, 75:274-280.
83. Desquiret V., Loiseau D., Jacques C., Douay O., Malthiery Y., Ritz P., et al. Dinitrophenol-induced mitochondrial uncoupling in vivo triggers respiratory adaptation in HepG2 cells. Biochim Biophys Acta 2006, 1757:21-30.
84. Dhanasekaran A., Kotamraju S., Karunakaran C., Kalivendi S.V., Thomas S., Joseph J., et al. Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic Biol Med 2005, 39:567-583.
85. Diano S., Matthews R.T., Patrylo P., Yang L., Beal M.F., Barnstable C.J., et al. Uncoupling protein 2 prevents neuronal death including that occurring during seizures: a mechanism for preconditioning. Endocrinology 2003, 144:5014-5021.
86. Dong K.K., Damaghi N., Kibitel J., Canning M.T., Smiles K.A., Yarosh D.B. A comparison of the relative antioxidant potency of L-ergothioneine and idebenone. J Cosmet Dermatol 2007, 6:183-188.
87. Doria E., Buonocore D., Focarelli A., Marzatico F. Relationship between human aging muscle and oxidative system pathway. Oxid Med Cell Longev 2012, 2012:830257.
88. Doughan A.K., Dikalov S.I. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid Redox Signal 2007, 9:1825-1836.
89. D'Souza G.G., Rammohan R., Cheng S.M., Torchilin V.P., Weissig V. DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J Control Release 2003, 92:189-197.
90. D'Souza G.G., Boddapati S.V., Weissig V. Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 2005, 5:352-358.
91. D'Souza G.G., Cheng S.M., Boddapati S.V., Horobin R.W., Weissig V. Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel. J Drug Target 2008, 16:578-585.
92. Echtay K.S. Mitochondrial uncoupling proteins-what is their physiological role?. Free Radic Biol Med 2007, 43:1351-1371.
93. Echtay K.S., Murphy M.P., Smith R.A., Talbot D.A., Brand M.D. Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants. J Biol Chem 2002, 277:47129-47135.
94. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415:96-99.
95. Echtay K.S., Esteves T.C., Pakay J.L., Jekabsons M.B., Lambert A.J., Portero-Otin M., et al. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 2003, 22:4103-4110.
96. Elmadfa I., Meyer A.L. Body composition, changing physiological functions and nutrient requirements of the elderly. Ann Nutr Metab 2008, 52(Suppl. 1):2-5.
97. Elswaifi S.F., Palmieri J.R., Hockey K.S., Rzigalinski B.A. Antioxidant nanoparticles for control of infectious disease. Infect Disord Drug Targets 2009, 9:445-452.
98. Esch F., Fabris S., Zhou L., Montini T., Africh C., Fornasiero P., et al. Electron localization determines defect formation on ceria substrates. Science 2005, 309:752-755.
99. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
100. Estevez A.Y., Pritchard S., Harper K., Aston J.W., Lynch A., Lucky J.J., et al. Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic Biol Med 2011, 51:1155-1163.
101. •-. Free Radic Biol Med 1993, 15:447-451.
102. Finch C.E., Pike M.C., Witten M. Slow mortality rate accelerations during aging in some animals approximate that of humans. Science 1990, 249:902-905.
103. Fink M.P., Macias C.A., Xiao J., Tyurina Y.Y., Delude R.L., Greenberger J.S., et al. Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted antioxidants. Crit Care Med 2007, 35:S461-S467.
104. Finkel T. Radical medicine: treating ageing to cure disease. Nat Rev Mol Cell Biol 2005, 6:971-976.
105. Fleury C., Neverova M., Collins S., Raimbault S., Champigny O., Levi-Meyrueis C., et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 1997, 15:269-272.
106. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B.F., Seta P., et al. Cellular localisation of a water-soluble fullerene derivative. Biochem Biophys Res Commun 2002, 294:116-119.
107. Franzoni F., Colognato R., Galetta F., Laurenza I., Barsotti M., Di Stefano R., et al. An in vitro study on the free radical scavenging capacity of ergothioneine: comparison with reduced glutathione, uric acid and trolox. Biomed Pharmacother 2006, 60:453-457.
108. Fridell Y.W., Sanchez-Blanco A., Silvia B.A., Helfand S.L. Targeted expression of the human uncoupling protein 2 (hUCP2) to adult neurons extends life span in the fly. Cell Metab 2005, 1:145-152.
109. Fridell Y.W., Hoh M., Kreneisz O., Hosier S., Chang C., Scantling D., et al. Increased uncoupling protein (UCP) activity in Drosophila insulin-producing neurons attenuates insulin signaling and extends lifespan. Aging (Albany NY) 2009, 1:699-713.
110. Fulda S., Galluzzi L., Kroemer G. Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 2010, 9:447-464.
111. Furukawa R., Yamada Y., Takenaga M., Igarashi R., Harashima H. Octaarginine-modified liposomes enhance the anti-oxidant effect of lecithinized superoxide dismutase by increasing its cellular uptake. Biochem Biophys Res Commun 2011, 404:796-801.
112. Gane E.J., Weilert F., Orr D.W., Keogh G.F., Gibson M., Lockhart M.M., et al. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int 2010, 30:1019-1026.
113. Gates A.C., Bernal-Mizrachi C., Chinault S.L., Feng C., Schneider J.G., Coleman T., et al. Respiratory uncoupling in skeletal muscle delays death and diminishes age-related disease. Cell Metab 2007, 6:497-505.
114. Gharbi N., Pressac M., Hadchouel M., Szwarc H., Wilson S.R., Moussa F. [60]Fullerene is a Powerful Antioxidant in Vivo with No Acute or Subacute Toxicity. Nano Lett 2005, 5:2578-2585.
115. Ghosh A., Chandran K., Kalivendi S.V., Joseph J., Antholine W.E., Hillard C.J., et al. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free Radic Biol Med 2010, 49:1674-1684.
116. Goh J., Enns L., Fatemie S., Hopkins H., Morton J., Pettan-Brewer C., et al. Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 2011, 11:191.
117. Graham D., Huynh N.N., Hamilton C.A., Beattie E., Smith R.A., Cocheme H.M., et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009, 54:322-328.
118. Grigat S., Harlfinger S., Pal S., Striebinger R., Golz S., Geerts A., et al. Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol 2007, 74:309-316.
119. Gruber J., Schaffer S., Halliwell B. The mitochondrial free radical theory of ageing-where do we stand?. Front Biosci 2008, 13:6554-6579.
120. Gruber J., Ng L.F., Poovathingal S.K., Halliwell B. Deceptively simple but simply deceptive-Caenorhabditis elegans lifespan studies: considerations for aging and antioxidant effects. FEBS Lett 2009, 583:3377-3387.
121. Gruber J., Ng L.F., Fong S., Wong Y.T., Koh S.A., Chen C.B., et al. Mitochondrial Changes in Ageing Caenorhabditis elegans - What Do We Learn from Superoxide Dismutase Knockouts?. PLoS One 2011, 6:e19444.
122. Grundemann D., Harlfinger S., Golz S., Geerts A., Lazar A., Berkels R., et al. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 2005, 102:5256-5261.
123. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature 2006, 444:868-874.
124. Hagen T.M., Liu J., Lykkesfeldt J., Wehr C.M., Ingersoll R.T., Vinarsky V., et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A 2002, 99:1870-1875.
125. Halliwell B. Oxidative stress in cell culture: an under-appreciated problem?. FEBS Lett 2003, 540:3-6.
126. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
127. Halliwell B. The antioxidant paradox: less paradoxical now?. Br J Clin Pharmacol 2012, 1365-2125.2012.04272.x. [Epub ahead of print].
128. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev 2012, 70:257-265.
129. Halliwell B., Gutteridge J.M.C. Free radicals in biology and medicine 2007, Oxford University Press, Oxford ; New York. 4th ed.
130. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 2004, 142:231-255.
131. Hanlon D.P. Interaction of ergothioneine with metal ions and metalloenzymes. J Med Chem 1971, 14:1084-1087.
132. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
133. Harman D. The biologic clock: the mitochondria?. J Am Geriatr Soc 1972, 20:145-147.
134. Harman D. Free radical theory of aging: dietary implications. Am J Clin Nutr 1972, 25:839-843.
135. Harper J.A., Stuart J.A., Jekabsons M.B., Roussel D., Brindle K.M., Dickinson K., et al. Artifactual uncoupling by uncoupling protein 3 in yeast mitochondria at the concentrations found in mouse and rat skeletal-muscle mitochondria. Biochem J 2002, 361:49-56.
136. Hartman P.E. Ergothioneine as antioxidant. Methods Enzymol 1990, 186:310-318.
137. Hayflick L. Biological aging is no longer an unsolved problem. Ann N Y Acad Sci 2007, 1100:1-13.
138. Heath H., Rimington C., Searle C.E., Lawson A. Some effects of administering ergothioneine to rats. Biochem J 1952, 50:530-533.
139. Heckert E.G., Karakoti A.S., Seal S., Self W.T. The role of cerium redox state in the SOD mimetic activity of nanoceria. Biomaterials 2008, 29:2705-2709.
140. Himms-Hagen J., Harper M.E. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 2001, 226:78-84.
141. Hiona A., Sanz A., Kujoth G.C., Pamplona R., Seo A.Y., Hofer T., et al. Mitochondrial DNA mutations induce mitochondrial dysfunction, apoptosis and sarcopenia in skeletal muscle of mitochondrial DNA mutator mice. PLoS One 2010, 5:e11468.
142. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
143. Horton K.L., Stewart K.M., Fonseca S.B., Guo Q., Kelley S.O. Mitochondria-penetrating peptides. Chem Biol 2008, 15:375-382.
144. Houtkooper R.H., Williams R.W., Auwerx J. Metabolic networks of longevity. Cell 2010, 142:9-14.
145. Humphrey D.M., Toivonen J.M., Giannakou M., Partridge L., Brand M.D. Expression of human uncoupling protein-3 in Drosophila insulin-producing cells increases insulin-like peptide (DILP) levels and shortens lifespan. Exp Gerontol 2009, 44:316-327.
146. Hur J.H., Cho J., Walker D.W. Aging: Dial M for Mitochondria. Aging (Albany NY) 2010, 2:69-73.
147. Hurtaud C., Gelly C., Bouillaud F., Levi-Meyrueis C. Translation control of UCP2 synthesis by the upstream open reading frame. Cell Mol Life Sci 2006, 63:1780-1789.
148. Hurtaud C., Gelly C., Chen Z., Levi-Meyrueis C., Bouillaud F. Glutamine stimulates translation of uncoupling protein 2mRNA. Cell Mol Life Sci 2007, 64:1853-1860.
149. Iser W.B., Kim D., Bachman E., Wolkow C. Examination of the requirement for ucp-4, a putative homolog of mammalian uncoupling proteins, for stress tolerance and longevity in C. elegans. Mech Ageing Dev 2005, 126:1090-1096.
150. Jaburek M., Miyamoto S., Di Mascio P., Garlid K.D., Jezek P. Hydroperoxy fatty acid cycling mediated by mitochondrial uncoupling protein UCP2. J Biol Chem 2004, 279:53097-53102.
151. James A.M., Cocheme H.M., Smith R.A., Murphy M.P. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J Biol Chem 2005, 280:21295-21312.
152. James A.M., Sharpley M.S., Manas A.R., Frerman F.E., Hirst J., Smith R.A., et al. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J Biol Chem 2007, 282:14708-14718.
153. Jiang J., Kurnikov I., Belikova N.A., Xiao J., Zhao Q., Amoscato A.A., et al. Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides. J Pharmacol Exp Ther 2007, 320:1050-1060.
154. Jiang J., Belikova N.A., Hoye A.T., Zhao Q., Epperly M.W., Greenberger J.S., et al. A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation. Int J Radiat Oncol Biol Phys 2008, 70:816-825.
155. Jiang J., Stoyanovsky D.A., Belikova N.A., Tyurina Y.Y., Zhao Q., Tungekar M.A., et al. A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator. Radiat Res 2009, 172:706-717.
156. Kagan V.E., Bayir H.A., Belikova N.A., Kapralov O., Tyurina Y.Y., Tyurin V.A., et al. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med 2009, 46:1439-1453.
157. Kajita M., Hikosaka K., Iitsuka M., Kanayama A., Toshima N., Miyamoto Y. Platinum nanoparticle is a useful scavenger of superoxide anion and hydrogen peroxide. Free Radic Res 2007, 41:615-626.
158. Kalil C.L., Fachinello F.Z., Lamb F.M., Comunello L.N. Use of oral isotretinoin in photoaging therapy. Skinmed 2008, 7:10-14.
159. Kalyanaraman B. Oxidative chemistry of fluorescent dyes: implications in the detection of reactive oxygen and nitrogen species. Biochem Soc Trans 2011, 39:1221-1225.
160. Kanai A., Zabbarova I., Amoscato A., Epperly M., Xiao J., Wipf P. Mitochondrial targeting of radioprotectants using peptidyl conjugates. Org Biomol Chem 2007, 5:307-309.
161. Karakelides H., Irving B.A., Short K.R., O'Brien P., Nair K.S. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 2010, 59:89-97.
162. Kawano H., Otani M., Takeyama K., Kawai Y., Mayumi T., Hama T. Studies on ergothioneine. VI. Distribution and fluctuations of ergothioneine in rats. Chem Pharm Bull(Tokyo) 1982, 30:1760-1765.
163. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 2001, 276:4588-4596.
164. Kim M.S., Park J.Y., Namkoong C., Jang P.G., Ryu J.W., Song H.S., et al. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat Med 2004, 10:727-733.
165. Kim J., Takahashi M., Shimizu T., Shirasawa T., Kajita M., Kanayama A., et al. Effects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegans. Mech Ageing Dev 2008, 129:322-331.
166. Kim J., Shirasawa T., Miyamoto Y. The effect of TAT conjugated platinum nanoparticles on lifespan in a nematode Caenorhabditis elegans model. Biomaterials 2010, 31:5849-5854.
167. Klingenberg M., Appel M. The uncoupling protein dimer can form a disulfide cross-link between the mobile C-terminal SH groups. Eur J Biochem 1989, 180:123-131.
168. Kogure K., Akita H., Yamada Y., Harashima H. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev 2008, 60:559-571.
169. Kohl E., Steinbauer J., Landthaler M., Szeimies R.M. Skin ageing. J Eur Acad Dermatol Venereol 2011, 25:873-884.
170. Kontani Y., Wang Y., Kimura K., Inokuma K.I., Saito M., Suzuki-Miura T., et al. UCP1 deficiency increases susceptibility to diet-induced obesity with age. Aging Cell 2005, 4:147-155.
171. Koopman W.J., Verkaart S., Visch H.J., van der Westhuizen F.H., Murphy M.P., van den Heuvel L.W., et al. Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. Am J Physiol Cell Physiol 2005, 288:C1440-C1450.
172. Korshunov S.S., Skulachev V.P., Starkov A.A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997, 416:15-18.
173. Korsvik C., Patil S., Seal S., Self W.T. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb) 2007, 1056-1058.
174. Krauss S., Zhang C.Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grey S.T., et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003, 112:1831-1842.
175. Kruk J., Jemiola-Rzeminska M., Strzalka K. Plastoquinol and α-tocopherol quinol are more active than ubiquinol and α-tocopherol in inhibition of lipid peroxidation. Chem Phys Lipids 1997, 87:73-80.
176. Krusic P.J., Wasserman E., Keizer P.N., Morton J.R., Preston K.F. Radical reactions of c60. Science 1991, 254:1183-1185.
177. Lackner L.L., Nunnari J. Small molecule inhibitors of mitochondrial division: tools that translate basic biological research into medicine. Chem Biol 2010, 17:578-583.
178. Lambert A.J., Brand M.D. Reactive oxygen species production by mitochondria. Methods Mol Biol 2009, 554:165-181.
179. Lamhonwah A.M., Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 2006, 345:1315-1325.
180. Landi F., Liperoti R., Fusco D., Mastropaolo S., Quattrociocchi D., Proia A., et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 2012, 13:121-126.
181. Landi F., Liperoti R., Russo A., Giovannini S., Tosato M., Capoluongo E., et al. Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study. Clin Nutr 2012, 5:652-658. 10.1016/j.clnu.2012.02.007. [Epub ahead of print].
182. Lasch J., Meye A., Taubert H., Koelsch R., Mansa-ard J., Weissig V. Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack. Biol Chem 1999, 380:647-652.
183. Lee C.K., Pugh T.D., Klopp R.G., Edwards J., Allison D.B., Weindruch R., et al. The impact of alpha-lipoic acid, coenzyme Q10 and caloric restriction on life span and gene expression patterns in mice. Free Radic Biol Med 2004, 36:1043-1057.
184. Lee M., Choi J.S., Choi M.J., Pak Y.K., Rhee B.D., Ko K.S. DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine. J Drug Target 2007, 15:115-122.
185. Lee H.Y., Choi C.S., Birkenfeld A.L., Alves T.C., Jornayvaz F.R., Jurczak M.J., et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab 2010, 12:668-674.
186. Lee C.G., Boyko E.J., Strotmeyer E.S., Lewis C.E., Cawthon P.M., Hoffman A.R., et al. Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus. J Am Geriatr Soc 2011, 59:1217-1224.
187. Lemire B.D., Behrendt M., DeCorby A., Gaskova D. C. elegans longevity pathways converge to decrease mitochondrial membrane potential. Mech Ageing Dev 2009, 130:461-465.
188. Leone E., Mann T. Ergothioneine in the seminal vesicle secretion. Nature 1951, 168:205-206.
189. Liberman E.A., Topaly V.P., Tsofina L.M., Jasaitis A.A., Skulachev V.P. Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 1969, 222:1076-1078.
190. Lints F.A., Lints C.V., Bullens P., Bourgois M., Delince J. Unexplained variations in life span of the Oregon-R strain of Drosophila melanogaster over a four-year period. Exp Gerontol 1989, 24:265-271.
191. Liochev S.I., Fridovich I. Lucigenin as mediator of superoxide production: revisited. Free Radic Biol Med 1998, 25:926-928.
192. Lipman R.D., Bronson R.T., Wu D., Smith D.E., Prior R., Cao G., et al. Disease incidence and longevity are unaltered by dietary antioxidant supplementation initiated during middle age in C57BL/6 mice. Mech Ageing Dev 1998, 103:269-284.
193. Liu S.S. Generating, partitioning, targeting and functioning of superoxide in mitochondria. Biosci Rep 1997, 17:259-272.
194. Liu J., Killilea D.W., Ames B.N. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid. Proc Natl Acad Sci U S A 2002, 99:1876-1881.
195. 2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009, 47:1101-1107.
196. Long J., Gao F., Tong L., Cotman C.W., Ames B.N., Liu J. Mitochondrial decay in the brains of old rats: ameliorating effect of alpha-lipoic acid and acetyl-L-carnitine. Neurochem Res 2009, 34:755-763.
197. Long L.H., Hoi A., Halliwell B. Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media. Arch Biochem Biophys 2010, 501:162-169.
198. Lopez-Lluch G., Irusta P.M., Navas P., de Cabo R. Mitochondrial biogenesis and healthy aging. Exp Gerontol 2008, 43:813-819.
199. Lou P.H., Hansen B.S., Olsen P.H., Tullin S., Murphy M.P., Brand M.D. Mitochondrial uncouplers with an extraordinary dynamic range. Biochem J 2007, 407:129-140.
200. Lowes D.A., Thottakam B.M., Webster N.R., Murphy M.P., Galley H.F. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 2008, 45:1559-1565.
201. Macias C.A., Chiao J.W., Xiao J., Arora D.S., Tyurina Y.Y., Delude R.L., et al. Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg 2007, 245:305-314.
202. Maddin S., Lauharanta J., Agache P., Burrows L., Zultak M., Bulger L. Isotretinoin improves the appearance of photodamaged skin: results of a 36-week, multicenter, double-blind, placebo-controlled trial. J Am Acad Dermatol 2000, 42:56-63.
203. Maechler P., Wollheim C.B. Mitochondrial function in normal and diabetic beta-cells. Nature 2001, 414:807-812.
204. Magwere T., West M., Riyahi K., Murphy M.P., Smith R.A., Partridge L. The effects of exogenous antioxidants on lifespan and oxidative stress resistance in Drosophila melanogaster. Mech Ageing Dev 2006, 127:356-370.
205. Manczak M., Mao P., Calkins M.J., Cornea A., Reddy A.P., Murphy M.P., et al. Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 2010, 20(Suppl. 2):S609-S631.
206. Marthandan S., Murphy M.P., Billett E., Barnett Y. An investigation of the effects of MitoQ on human peripheral mononuclear cells. Free Radic Res 2011, 45:351-358.
207. Martin R., Menchon C., Apostolova N., Victor V.M., Alvaro M., Herance J.R., et al. Nano-jewels in biology. Gold and platinum on diamond nanoparticles as antioxidant systems against cellular oxidative stress. ACS Nano 2010, 4:6957-6965.
208. Mattiasson G., Shamloo M., Gido G., Mathi K., Tomasevic G., Yi S., et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 2003, 9:1062-1068.
209. Mattson M.P. Perspective: Does brown fat protect against diseases of aging?. Ageing Res Rev 2010, 9:69-76.
210. McDonald R.B., Walker K.M., Warman D.B., Griffey S.M., Warden C.H., Ramsey J.J., et al. Characterization of survival and phenotype throughout the life span in UCP2/UCP3 genetically altered mice. Exp Gerontol 2008, 43:1061-1068.
211. Melville DB. Ergothioneine. Vitamins and Hormones-Advances in Research and Applications. 1959;17:155-204.
212. Melville D.B., Horner W.H., Lubschez R. Tissue ergothioneine. J Biol Chem 1954, 206:221-228.
213. Mercken E.M., Calvert L.D., Singh S.J., Hageman G.J., Schols A.M., Steiner M.C. Dichloroacetate modulates the oxidative stress and inflammatory response to exercise in COPD. Chest 2009, 136:744-751.
214. Meydani M., Lipman R.D., Han S.N., Wu D., Beharka A., Martin K.R., et al. The effect of long-term dietary supplementation with antioxidants. Ann N Y Acad Sci 1998, 854:352-360.
215. Miquel E., Cassina A., Martinez-Palma L., Bolatto C., Trias E., Gandelman M., et al. Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis. PLoS One 2012, 7:e34776.
216. Mitragotri S. In drug delivery, shape does matter. Pharm Res 2009, 26:232-234.
217. Mitsuyama H., May J.M. Uptake and antioxidant effects of ergothioneine in human erythrocytes. Clin Sci (Lond) 1999, 97:407-411.
218. Miwa S., Brand M.D. Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochem Soc Trans 2003, 31:1300-1301.
219. Mizuguchi Y., Chen J., Seshan S.V., Poppas D.P., Szeto H.H., Felsen D. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol 2008, 295:F1545-F1553.
220. Moini H., Packer L., Saris N.E. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 2002, 182:84-90.
221. Mookerjee S.A., Divakaruni A.S., Jastroch M., Brand M.D. Mitochondrial uncoupling and lifespan. Mech Ageing Dev 2010, 131:463-472.
222. Morcos M., Du X., Pfisterer F., Hutter H., Sayed A.A., Thornalley P., et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell 2008, 7:260-269.
223. Motohash N., Mori I., Sugiura Y., Tanaka H. Metal-complexes of ergothioneine. Chem Pharm Bull 1974, 22:654-657.
224. Motohashi N., Mori I. Thiol-induced hydroxyl radical formation and scavenger effect of thiocarbamides on hydroxyl radicals. J Inorg Biochem 1986, 26:205-212.
225. Motohashi N., Mori I., Sugiura Y. Complexing of copper ion by ergothioneine. Chem Pharm Bull(Tokyo) 1976, 24:2364-2368.
226. Muro S., Garnacho C., Champion J.A., Leferovich J., Gajewski C., Schuchman E.H., et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther 2008, 16:1450-1458.
227. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem J 2009, 417:1-13.
228. Murphy M.P. Mitochondria-a neglected drug target. Curr Opin Investig Drugs 2009, 10:1022-1024.
229. Murphy M.P. Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antioxid Redox Signal 2012, 16:476-495.
230. Murphy M.P., Smith R.A. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 2007, 47:629-656.
231. Murphy M.P., Holmgren A., Larsson N.G., Halliwell B., Chang C.J., Kalyanaraman B., et al. Unraveling the biological roles of reactive oxygen species. Cell Metab 2011, 13:361-366.
232. Nehilla B.J., Bergkvist M., Popat K.C., Desai T.A. Purified and surfactant-free coenzyme Q10-loaded biodegradable nanoparticles. Int J Pharm 2008, 348:107-114.
233. Neroev V.V., Archipova M.M., Bakeeva L.E., Fursova A., Grigorian E.N., Grishanova A.Y., et al. Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc) 2008, 73:1317-1328.
234. Niu J., Azfer A., Rogers L.M., Wang X., Kolattukudy P.E. Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc Res 2007, 73:549-559.
235. O'Malley Y., Fink B.D., Ross N.C., Prisinzano T.E., Sivitz W.I. Reactive oxygen and targeted antioxidant administration in endothelial cell mitochondria. J Biol Chem 2006, 281:39766-39775.
236. Orsucci D., Mancuso M., Ienco E.C., LoGerfo A., Siciliano G. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Curr Med Chem 2011, 18:4053-4064.
237. Packer L., Cadenas E. Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling. J Clin Biochem Nutr 2011, 48:26-32.
238. Padalko V.I. Uncoupler of oxidative phosphorylation prolongs the lifespan of Drosophila. Biochemistry (Mosc) 2005, 70:986-989.
239. Papa S., Skulachev V.P. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997, 174:305-319.
240. Parascandola J. Dinitrophenol and bioenergetics: an historical perspective. Mol Cell Biochem 1974, 5:69-77.
241. Parise G., De Lisio M. Mitochondrial theory of aging in human age-related sarcopenia. Interdiscip Top Gerontol 2010, 37:142-156.
242. Partridge L., Gems D. Benchmarks for ageing studies. Nature 2007, 450:165-167.
243. Passos J.F., Saretzki G., Ahmed S., Nelson G., Richter T., Peters H., et al. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 2007, 5:e110.
244. Paul B.D., Snyder S.H. The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ 2010, 17:1134-1140.
245. Pecqueur C., Alves-Guerra M.C., Gelly C., Levi-Meyrueis C., Couplan E., Collins S., et al. Uncoupling protein 2, in vivo distribution, induction upon oxidative stress, and evidence for translational regulation. J Biol Chem 2001, 276:8705-8712.
246. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2:751-760.
247. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
248. Petri S., Kiaei M., Damiano M., Hiller A., Wille E., Manfredi G., et al. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem 2006, 98:1141-1148.
249. Pettegrew J.W., Levine J., McClure R.J. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol Psychiatry 2000, 5:616-632.
250. Pirmohamed T., Dowding J.M., Singh S., Wasserman B., Heckert E., Karakoti A.S., et al. Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem Commun (Camb) 2010, 46:2736-2738.
251. Porteous C.M., Logan A., Evans C., Ledgerwood E.C., Menon D.K., Aigbirhio F., et al. Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. Biochim Biophys Acta 2010, 1800:1009-1017.
252. Prenner E.J., Lewis R.N., Neuman K.C., Gruner S.M., Kondejewski L.H., Hodges R.S., et al. Nonlamellar phases induced by the interaction of gramicidin S with lipid bilayers. A possible relationship to membrane-disrupting activity. Biochemistry 1997, 36:7906-7916.
253. Puig O., Marr M.T., Ruhf M.L., Tjian R. Control of cell number by Drosophila FOXO: downstream and feedback regulation of the insulin receptor pathway. Genes Dev 2003, 17:2006-2020.
254. Pun P.B., Gruber J., Tang S.Y., Schaffer S., Ong R.L., Fong S., et al. Ageing in nematodes: do antioxidants extend lifespan in Caenorhabditis elegans?. Biogerontology 2010, 11:17-30.
255. Quin C., Robertson L., McQuaker S.J., Price N.C., Brand M.D., Hartley R.C. Caged mitochondrial uncouplers that are released in response to hydrogen peroxide. Tetrahedron 2010, 66:2384-2389.
256. Rajagopalan M.S., Gupta K., Epperly M.W., Franicola D., Zhang X., Wang H., et al. The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair. In Vivo 2009, 23:717-726.
257. Rao V.A., Klein S.R., Bonar S.J., Zielonka J., Mizuno N., Dickey J.S., et al. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. J Biol Chem 2010, 285:34447-34459.
258. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J 1992, 6:3379-3386.
259. Reglinski J., Smith W.E., Sturrock R.D. Spin-echo 1H NMR detected response of ergothioneine to oxidative stress in the intact human erythrocyte. Magn Reson Med 1988, 6:217-223.
260. Rodriguez-Cuenca S., Cocheme H.M., Logan A., Abakumova I., Prime T.A., Rose C., et al. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 2010, 48:161-172.
261. Roginsky V.A., Tashlitsky V.N., Skulachev V.P. Chain-breaking antioxidant activity of reduced forms of mitochondria-targeted quinones, a novel type of geroprotectors. Aging (Albany NY) 2009, 1:481-489.
262. Ross M.F., Kelso G.F., Blaikie F.H., James A.M., Cocheme H.M., Filipovska A., et al. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc) 2005, 70:222-230.
263. Rougee M., Bensasson R.V., Land E.J., Pariente R. Deactivation of singlet molecular-oxygen by thiols and related compounds, possible protectors against skin photosensitivity. Photochem Photobiol 1988, 47:485-489.
264. Rzigalinski B.A., Meehan K., Davis R.M., Xu Y., Miles W.C., Cohen C.A. Radical nanomedicine. Nanomedicine (Lond) 2006, 1:399-412.
265. Salt H.B. The ergothioneine content of the blood in health and disease. Biochem J 1931, 25:1712-1719.
266. Santos J.H., Meyer J.N., Mandavilli B.S., Van Houten B. Quantitative PCR-based measurement of nuclear and mitochondrial DNA damage and repair in mammalian cells. Methods Mol Biol 2006, 314:183-199.
267. Saretzki G., Murphy M.P., von Zglinicki T. MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2003, 2:141-143.
268. Schaffer S., Gruber J., Ng L.F., Fong S., Wong Y.T., Tang S.Y., et al. The effect of dichloroacetate on health- and lifespan in C. elegans. Biogerontology 2011, 12:195-209.
269. Schlotterer A., Kukudov G., Bozorgmehr F., Hutter H., Du X., Oikonomou D., et al. C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes 2009, 58:2450-2456.
270. Schlotterer A., Hamann A., Kukudov G., Ibrahim Y., Heckmann B., Bozorgmehr F., et al. Apurinic/apyrimidinic endonuclease 1, p53, and thioredoxin are linked in control of aging in C. elegans. Aging Cell 2010, 9:420-432.
271. Schmelzer C., Doring F. Micronutrient special issue: Coenzyme Q(10) requirements for DNA damage prevention. Mutat Res 2012, 733:61-68.
272. Schrauwen P., Hesselink M.K. The role of uncoupling protein 3 in fatty acid metabolism: protection against lipotoxicity?. Proc Nutr Soc 2004, 63:287-292.
273. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
274. Schubert D., Dargusch R., Raitano J., Chan S.W. Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophys Res Commun 2006, 342:86-91.
275. Sendagorta E., Lesiewicz J., Armstrong R.B. Topical isotretinoin for photodamaged skin. J Am Acad Dermatol 1992, 27:S15-S18.
276. Severin F.F., Severina I.I., Antonenko Y.N., Rokitskaya T.I., Cherepanov D.A., Mokhova E.N., et al. Penetrating cation/fatty acid anion pair as a mitochondria-targeted protonophore. Proc Natl Acad Sci U S A 2010, 107:663-668.
277. Shires T.K., Brummel M.C., Pulido J.S., Stegink L.D. Ergothioneine distribution in bovine and porcine ocular tissues. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1997, 117:117-120.
278. Skulachev V.P. Uncoupling: new approaches to an old problem of bioenergetics. Biochim Biophys Acta 1998, 1363:100-124.
279. Skulachev V.P. A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects. Biochem Biokhim 2007, 72:1385-1396.
280. Skulachev M.V., Antonenko Y.N., Anisimov V.N., Chernyak B.V., Cherepanov D.A., Chistyakov V.A., et al. Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies. Curr Drug Targets 2011, 12:800-826.
281. Smith R.A., Murphy M.P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann N Y Acad Sci 2010, 1201:96-103.
282. Smith R.A., Murphy M.P. Mitochondria-targeted antioxidants as therapies. Discov Med 2011, 11:106-114.
283. Smith R.A., Porteous C.M., Coulter C.V., Murphy M.P. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 1999, 263:709-716.
284. Smith R.A., Porteous C.M., Gane A.M., Murphy M.P. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A 2003, 100:5407-5412.
285. Snow B.J., Rolfe F.L., Lockhart M.M., Frampton C.M., O'Sullivan J.D., Fung V., et al. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Mov Disord 2010, 25:1670-1674.
286. Sohal R.S., Mockett R.J., Orr W.C. Mechanisms of aging: an appraisal of the oxidative stress hypothesis. Free Radic Biol Med 2002, 33:575-586.
287. Song W., Shin J., Lee J., Kim H., Oh D., Edelberg J.M., et al. A potent opiate agonist protects against myocardial stunning during myocardial ischemia and reperfusion in rats. Coron Artery Dis 2005, 16:407-410.
288. Spasojevic I., Liochev S.I., Fridovich I. Lucigenin: redox potential in aqueous media and redox cycling with O-(2) production. Arch Biochem Biophys 2000, 373:447-450.
289. Speakman J.R., Talbot D.A., Selman C., Snart S., McLaren J.S., Redman P., et al. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 2004, 3:87-95.
290. Speisky H., Gomez M., Carrasco-Pozo C., Pastene E., Lopez-Alarcon C., Olea-Azar C. Cu(I)-glutathione complex: a potential source of superoxide radicals generation. Bioorg Med Chem 2008, 16:6568-6574.
291. Stabler S.P., Sekhar J., Allen R.H., O'Neill H.C., White C.W. Alpha-lipoic acid induces elevated S-adenosylhomocysteine and depletes S-adenosylmethionine. Free Radic Biol Med 2009, 47:1147-1153.
292. Stacpoole P.W. The pyruvate dehydrogenase complex as a therapeutic target for age-related diseases. Aging Cell 2012, 11:371-377.
293. Stacpoole P.W., Henderson G.N., Yan Z., Cornett R., James M.O. Pharmacokinetics, metabolism and toxicology of dichloroacetate. Drug Metab Rev 1998, 30:499-539.
294. Stockl P., Zankl C., Hutter E., Unterluggauer H., Laun P., Heeren G., et al. Partial uncoupling of oxidative phosphorylation induces premature senescence in human fibroblasts and yeast mother cells. Free Radic Biol Med 2007, 43:947-958.
295. Sullivan PG. Nanotubes as Mitochondrial Uncouplers. United States patent US 7,919,699 B2 Apr 5,2011. 2010.
296. Sun L.Y. Hippocampal IGF-1 expression, neurogenesis and slowed aging: clues to longevity from mutant mice. Age (Dordr) 2006, 28:181-189.
297. Supinski G.S., Murphy M.P., Callahan L.A. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1095-R1102.
298. Suzuki R., Yamada Y., Harashima H. Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device. Biol Pharm Bull 2007, 30:758-762.
299. Swarnakar N.K., Jain A.K., Singh R.P., Godugu C., Das M., Jain S. Oral bioavailability, therapeutic efficacy and reactive oxygen species scavenging properties of coenzyme Q10-loaded polymeric nanoparticles. Biomaterials 2011, 32:6860-6874.
300. Swerdlow R.H. Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem. Antioxid Redox Signal 2007, 9:1591-1603.
301. Szeto H.H. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 2006, 8:E521-E531.
302. Szeto H.H. Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 2008, 10:601-619.
303. Tainter M.L. Growth, life-span and food intake of white rats fed dinitrophenol throughout life. J Pharmacol Exp Ther 1938, 63:51-57.
304. Tang S.Y., Halliwell B. Medicinal plants and antioxidants: what do we learn from cell culture and Caenorhabditis elegans studies?. Biochem Biophys Res Commun 2010, 394:1-5.
305. Tarnopolsky M.A. The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev 2008, 60:1561-1567.
306. Tarnuzzer R.W., Colon J., Patil S., Seal S. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005, 5:2573-2577.
307. Theodoratos A., Blackburn A.C., Cappello J., Tummala P., Dahlstrom J.E., Board P.G. Dichloroacetic acid up-regulates hepatic glutathione synthesis via the induction of glutamate-cysteine ligase. Biochem Pharmacol 2012, 83:427-433.
308. Thomas D.A., Stauffer C., Zhao K., Yang H., Sharma V.K., Szeto H.H., et al. Mitochondrial targeting with antioxidant peptide SS-31 prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function. J Am Soc Nephrol 2007, 18:213-222.
309. Trnka J., Blaikie F.H., Smith R.A., Murphy M.P. A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radic Biol Med 2008, 44:1406-1419.
310. Trnka J., Blaikie F.H., Logan A., Smith R.A., Murphy M.P. Antioxidant properties of MitoTEMPOL and its hydroxylamine. Free Radic Res 2009, 43:4-12.
311. Tsybul'ko E.A., Roshina N.V., Rybina O.Y., Pasyukova E.G. Mitochondria-targeted plastoquinone derivative SkQ1 increases early reproduction of Drosophila melanogaster at the cost of early survival. Biochemistry (Mosc) 2010, 75:265-268.
312. Tyurina Y.Y., Tungekar M.A., Jung M.Y., Tyurin V.A., Greenberger J.S., Stoyanovsky D.A., et al. Mitochondria targeting of non-peroxidizable triphenylphosphonium conjugated oleic acid protects mouse embryonic cells against apoptosis: role of cardiolipin remodeling. FEBS Lett 2012, 586:235-241.
313. United Nations World Population Ageing: 1950 - 2050. Department of economic and social affairs populatin devision 2001.
314. Vaidya B., Mishra N., Dube D., Tiwari S., Vyas S.P. Targeted nucleic acid delivery to mitochondria. Curr Gene Ther 2009, 9:475-486.
315. Vidal-Puig A., Solanes G., Grujic D., Flier J.S., Lowell B.B. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem Biophys Res Commun 1997, 235:79-82.
316. Vidal-Puig A.J., Grujic D., Zhang C.Y., Hagen T., Boss O., Ido Y., et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000, 275:16258-16266.
317. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360:1518-1525.
318. Wall B.T., Stephens F.B., Constantin-Teodosiu D., Marimuthu K., Macdonald I.A., Greenhaff P.L. Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol 2011, 589:963-973.
319. Wallace D.C. Colloquium paper: bioenergetics, the origins of complexity, and the ascent of man. Proc Natl Acad Sci U S A 2010, 107(Suppl. 2):8947-8953.
320. Wanagat J., Dai D.F., Rabinovitch P. Mitochondrial oxidative stress and mammalian healthspan. Mech Ageing Dev 2010, 131:527-535.
321. Wang Z., Al-Regaiey K.A., Masternak M.M., Bartke A. Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J Gerontol A Biol Sci Med Sci 2006, 61:323-331.
322. Wang L., Liu Y., Li W., Jiang X., Ji Y., Wu X., et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 2011, 11:772-780.
323. Wee L.M., Long L.H., Whiteman M., Halliwell B. Factors affecting the ascorbate- and phenolic-dependent generation of hydrogen peroxide in Dulbecco's Modified Eagles Medium. Free Radic Res 2003, 37:1123-1130.
324. Weissig V., Lizano C., Torchilin V.P. Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes. Drug Deliv 2000, 7:1-5.
325. Weissig V., D'Souza G.G., Torchilin V.P. DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J Control Release 2001, 75:401-408.
326. Whiteman M., Armstrong J.S., Cheung N.S., Siau J.L., Rose P., Schantz J.T., et al. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J 2004, 18:1395-1397.
327. Whiteman M., Spencer J.P., Szeto H.H., Armstrong J.S. Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury?. Antioxid Redox Signal 2008, 10:641-650.
328. Wipf P., Xiao J., Jiang J., Belikova N.A., Tyurin V.A., Fink M.P., et al. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J Am Chem Soc 2005, 127:12460-12461.
329. Wolkow C.A., Iser W.B. Uncoupling protein homologs may provide a link between mitochondria, metabolism and lifespan. Ageing Res Rev 2006, 5:196-208.
330. Yamada Y., Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 2008, 60:1439-1462.
331. Yamada Y., Shinohara Y., Kakudo T., Chaki S., Futaki S., Kamiya H., et al. Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy. Int J Pharm 2005, 303:1-7.
332. Yamada Y., Akita H., Kamiya H., Kogure K., Yamamoto T., Shinohara Y., et al. MITO-Porter: A liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta 2008, 1778:423-432.
333. Yang L., Zhao K., Calingasan N.Y., Luo G., Szeto H.H., Beal M.F. Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Antioxid Redox Signal 2009, 11:2095-2104.
334. Yasuzaki Y., Yamada Y., Harashima H. Mitochondrial matrix delivery using MITO-Porter, a liposome-based carrier that specifies fusion with mitochondrial membranes. Biochem Biophys Res Commun 2010, 397:181-186.
335. Yen W.L., Klionsky D.J. How to live long and prosper: autophagy, mitochondria, and aging. Physiology (Bethesda) 2008, 23:248-262.
336. Yousif L.F., Stewart K.M., Kelley S.O. Targeting mitochondria with organelle-specific compounds: strategies and applications. Chembiochem 2009, 10:1939-1950.
337. Yurova M.N., Piskunova T.S., Zabezhinski M.A., Popovich I.G., Tyndyk M.L., Anisimov V.N. Effects of SkQl on life span and spontaneous carcinogenesis in female mice of three various strains. From Homo Sapiens to Homo Sapiens Liberatus International workshop, Moscow, MSU May25-26, 2010 2010.
338. Zhang C.Y., Baffy G., Perret P., Krauss S., Peroni O., Grujic D., et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001, 105:745-755.
339. Zhang E., Zhang C., Su Y., Cheng T., Shi C. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov Today 2011, 16:140-146.
340. Zhao K., Luo G., Zhao G.M., Schiller P.W., Szeto H.H. Transcellular transport of a highly polar 3+ net charge opioid tetrapeptide. J Pharmacol Exp Ther 2003, 304:425-432.
341. Zhao K., Zhao G.M., Wu D., Soong Y., Birk A.V., Schiller P.W., et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004, 279:34682-34690.
342. Zhao K., Luo G., Giannelli S., Szeto H.H. Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochem Pharmacol 2005, 70:1796-1806.
343. Zhu B.Z., Mao L., Fan R.M., Zhu J.G., Zhang Y.N., Wang J., et al. Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. Chem Res Toxicol 2011, 24:30-34.
344. Zielonka J., Kalyanaraman B. Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth. Free Radic Biol Med 2010, 48:983-1001.
345. Zingaretti M.C., Crosta F., Vitali A., Guerrieri M., Frontini A., Cannon B., et al. The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue. FASEB J 2009, 23:3113-3120.